Release Date: 29/01/16 14:36 Summary: December 2015 Quarterly Report Price Sensitive: Yes Download Document 330.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%